An editorial in The British Medical Journal entitled "Blood Donors and the Transfusion Service" argued that the blood services were ill-equipped to do the job as a modern transfusion service, suggesting that the "shortage" of blood and therefore plasma, allowing entry to the UK of the products of pharmaceutical companies, was not a real shortage, but a consequence of poor administration, organisation and underfunding.